These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32577751)

  • 1. De novo evolved gene product NCYM in the pathogenesis and clinical outcome of human neuroblastomas and other cancers.
    Suenaga Y; Nakatani K; Nakagawara A
    Jpn J Clin Oncol; 2020 Aug; 50(8):839-846. PubMed ID: 32577751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomas.
    Suenaga Y; Islam SM; Alagu J; Kaneko Y; Kato M; Tanaka Y; Kawana H; Hossain S; Matsumoto D; Yamamoto M; Shoji W; Itami M; Shibata T; Nakamura Y; Ohira M; Haraguchi S; Takatori A; Nakagawara A
    PLoS Genet; 2014 Jan; 10(1):e1003996. PubMed ID: 24391509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas.
    Kaneko Y; Suenaga Y; Islam SM; Matsumoto D; Nakamura Y; Ohira M; Yokoi S; Nakagawara A
    Cancer Sci; 2015 Jul; 106(7):840-7. PubMed ID: 25880909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCYM promotes calpain-mediated Myc-nick production in human MYCN-amplified neuroblastoma cells.
    Shoji W; Suenaga Y; Kaneko Y; Islam SM; Alagu J; Yokoi S; Nio M; Nakagawara A
    Biochem Biophys Res Commun; 2015 Jun; 461(3):501-6. PubMed ID: 25896758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAp63 represses transcription of MYCN/NCYM gene and its high levels of expression are associated with favorable outcome in neuroblastoma.
    Suenaga Y; Yamamoto M; Sakuma T; Sasada M; Fukai F; Ohira M; Yamaguchi Y; Yamamoto T; Ando K; Ozaki T; Nakagawara A
    Biochem Biophys Res Commun; 2019 Oct; 518(2):311-318. PubMed ID: 31427086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCYM is upregulated by lncUSMycN and modulates N-Myc expression.
    Liu PY; Atmadibrata B; Mondal S; Tee AE; Liu T
    Int J Oncol; 2016 Dec; 49(6):2464-2470. PubMed ID: 27748806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells.
    O'Brien EM; Selfe JL; Martins AS; Walters ZS; Shipley JM
    BMC Cancer; 2018 Feb; 18(1):217. PubMed ID: 29466962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary Structure of Human
    Matsuo T; Nakatani K; Setoguchi T; Matsuo K; Tamada T; Suenaga Y
    Front Oncol; 2021; 11():688852. PubMed ID: 34497756
    [No Abstract]   [Full Text] [Related]  

  • 9. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
    Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q
    Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYCNOS functions as an antisense RNA regulating MYCN.
    Vadie N; Saayman S; Lenox A; Ackley A; Clemson M; Burdach J; Hart J; Vogt PK; Morris KV
    RNA Biol; 2015; 12(8):893-9. PubMed ID: 26156430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
    Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
    Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterization of human
    Yamamoto S; Kono F; Nakatani K; Hirose M; Horii K; Hippo Y; Tamada T; Suenaga Y; Matsuo T
    Front Oncol; 2023; 13():1213678. PubMed ID: 38074684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LSINCT5 activates Wnt/β-catenin signaling by interacting with NCYM to promote bladder cancer progression.
    Zhu X; Li Y; Zhao S; Zhao S
    Biochem Biophys Res Commun; 2018 Jul; 502(3):299-306. PubMed ID: 29772237
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Mouhand A; Nakatani K; Kono F; Hippo Y; Matsuo T; Barthe P; Peters J; Suenaga Y; Tamada T; Roumestand C
    Biomol NMR Assign; 2024 Jun; 18(1):65-70. PubMed ID: 38526839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation.
    Saengwimol D; Chittavanich P; Laosillapacharoen N; Srimongkol A; Chaitankar V; Rojanaporn D; Aroonroch R; Suktitipat B; Saisawang C; Svasti S; Hongeng S; Kaewkhaw R
    Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):8. PubMed ID: 33270844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanisms of
    Liu R; Shi P; Wang Z; Yuan C; Cui H
    Front Oncol; 2020; 10():625332. PubMed ID: 33614505
    [No Abstract]   [Full Text] [Related]  

  • 17. A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma.
    Montemurro L; Raieli S; Angelucci S; Bartolucci D; Amadesi C; Lampis S; Scardovi AL; Venturelli L; Nieddu G; Cerisoli L; Fischer M; Teti G; Falconi M; Pession A; Hrelia P; Tonelli R
    Cancer Res; 2019 Dec; 79(24):6166-6177. PubMed ID: 31615807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma.
    Manohar CF; Salwen HR; Brodeur GM; Cohn SL
    Genes Chromosomes Cancer; 1995 Nov; 14(3):196-203. PubMed ID: 8589036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of NLRR3 orphan receptor gene is negatively regulated by MYCN and Miz-1, and its downregulation is associated with unfavorable outcome in neuroblastoma.
    Akter J; Takatori A; Hossain MS; Ozaki T; Nakazawa A; Ohira M; Suenaga Y; Nakagawara A
    Clin Cancer Res; 2011 Nov; 17(21):6681-92. PubMed ID: 21908575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma.
    Muth D; Ghazaryan S; Eckerle I; Beckett E; Pöhler C; Batzler J; Beisel C; Gogolin S; Fischer M; Henrich KO; Ehemann V; Gillespie P; Schwab M; Westermann F
    Cancer Res; 2010 May; 70(9):3791-802. PubMed ID: 20424123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.